← Leaderboards
Mohamed Sorror
Fred Hutchinson Cancer Center
$5,016,720
Attributed
$5,016,720
Total exposure
3
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $963.9K · FY2007–24$1M$750K$500K$250K$0
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$5,016,720 · 3
By mechanism
R01$4,103,352 · 1
R00$735,049 · 1
K99$178,319 · 1
Top collaborators
No co-investigators on record.
Most similar at Fred Hutchinson Cancer Center
Same institution · by research overlap
- Marie Bleakley$9,428,742
- Damian J. Green$13,222,447
- Frederick R Appelbaum$23,398,619
- Hans-Peter Kiem$98,160,227
- Stephen J. Tapscott$35,231,470
Others in their field
Top investigators on “Evaluation”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- David Heimbrook · Leidos Biomedical Research, Inc.$564,050,020
- Lawrence Corey · Fred Hutchinson Cancer Center$559,122,174
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$489,869,793
- Jeffrey P Krischer · University Of South Florida$466,087,841
- Judith S. Currier · University Of California Los Angeles$403,175,569
Research focus
EvaluationEnrollmentAgingProceduresEnsureSupportive CarePrognosticTransplant RecipientsComorbidityComorbidity IndexProgramsTrainingProspectiveQuality Of LifeAllogenicBone Marrow TransplantationBloodMedicalBaseHomologous TransplantationFutureIndexingDecision MakingHigh Risk
Grant awards (12)
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$809,535
R01 · FY2024 · CA · contact PI
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$855,411
R01 · FY2023 · CA · contact PI
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$650,164
R01 · FY2021 · CA · contact PI
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$313,704
R01 · FY2021 · CA · contact PI
Cost of Cancer Supplement$1
R01 · FY2021 · CA · contact PI
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$690,341
R01 · FY2020 · CA · contact PI
Novel Intervention Approaches to Alleviate Allogeneic Transplant-Related Morbidity and Mortality$784,196
R01 · FY2018 · CA · contact PI
Impact of Comorbidities on Outcomes of Allogeneic Transplantation$237,049
R00 · FY2013 · HL · contact PI
Impact of Comorbidities on Outcomes of Allogeneic Transplantation$249,000
R00 · FY2012 · HL · contact PI
Impact of Comorbidities on Outcomes of Allogeneic Transplantation$249,000
R00 · FY2011 · HL · contact PI
Impact of Comorbidities on Outcomes of Allogeneic Transplantation$88,973
K99 · FY2008 · HL · contact PI
Impact of Comorbidities on Outcomes of Allogeneic Transplantation$89,346
K99 · FY2007 · HL · contact PI